杭州胡庆余堂药业有限公司
Hangzhou Hu Qingyu Tang Pharmaceutical Co., Ltd. is a 150+ year-old traditional Chinese medicine manufacturer (founded 1874) and Shanghai Pharmaceuticals subsidiary, producing 182 approved prescription, OTC, and health supplement products across 12 dosage forms for hospitals, pharmacies, and consumers in China.
- Company typePrivate
- Founded1874
- Headquarters杭州市, 浙江省, China
- Headcount11–50
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What 杭州胡庆余堂药业有限公司 does
杭州胡庆余堂药业有限公司 is a privately held traditional Chinese medicine (TCM) manufacturer headquartered in Hangzhou, China, and a subsidiary of the state-owned Shanghai Pharmaceuticals Group (上海医药集团). Founded in 1874 by Qing-dynasty merchant Hu Xueyan under the brand 胡庆余堂 ("Hu Qing Yu Tang") and historically styled "江南药王" (Medicine King of Jiangnan), the company operates a 107-acre GMP-certified manufacturing facility in Yuhang Economic and Technological Development Zone (relocated and certified in 2015) producing 182 nationally approved pharmaceutical products across 12 dosage forms including pills, powders, ointments, pellets, tablets, capsules, and granules.
The company's commercial portfolio spans three categories: prescription TCM drugs (处方药) including the flagship 胃复春片/胶囊 (Weifuchun — the only CFDA-approved TCM for gastric precancerous lesions) and 安宫牛黄丸 (a national essential and emergency rescue drug for stroke and high fever); over-the-counter TCM products (非处方药) including 阿胶 (Ejiao) and 强力枇杷露; and health supplements (保健品) such as 参参胶囊, 铁皮枫斗晶, and 蜂胶胶囊. Revenue is generated through one-time product sales via two primary channels: direct medical institution sales for prescription products distributed through national and provincial medical insurance formularies, and retail pharmacy distribution for OTC and supplement SKUs. Go-to-market relies on academic medical conference participation, clinical research presentation, and university partnerships (Zhejiang University of TCM, Tianjin University of TCM, Nanjing University of TCM) to build prescriber adoption. Pricing is not publicly disclosed and is channel-dependent on insurance reimbursement schedules and retail pharmacy agreements.
The business is anchored by regulatory exclusivity (National Class 2 Protected TCM Variety status for 胃复春), a 150+ year heritage brand, and preserved traditional preparation techniques (manual pill rolling, golden ladle silver pot processing), with differentiation supported by inclusion in national clinical treatment guidelines for gastric conditions. The company operates within China's East China region and distributes nationally through insurance and pharmacy channels, with no disclosed international expansion. Leadership includes Chairman 沈波 (Shanghai Pharmaceuticals executive director), Party Secretary 金强, and Managing Deputy General Manager 陆晓晶.
杭州胡庆余堂药业有限公司 firmographics
Firmographics- Name
- 杭州胡庆余堂药业有限公司
- Legal name
- 杭州胡庆余堂药业有限公司
- Website
- https://hqyt.com
- Company type
- Private
- Founded year
- 1874
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Hangzhou Hu Qingyu Tang Pharmaceutical Co., Ltd. is a 150+ year-old traditional Chinese medicine manufacturer (founded 1874) and Shanghai Pharmaceuticals subsidiary, producing 182 approved prescription, OTC, and health supplement products across 12 dosage forms for hospitals, pharmacies, and consumers in China.
- Ownership category
- akta.pro rank
杭州胡庆余堂药业有限公司 industry classification
Industry- Product category
- Traditional Chinese Medicine (TCM) Pharmaceuticals
- NAICS
- Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411)
- SIC
- Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Specialty Care Pharmaceuticals (HLAIAAAB)
- akta.pro secondary industries
- Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD), Eye, Ear & Nasal Care OTC (Eye Drops, Ear Drops/Wax Removal, Saline Sprays) (CRADAMAG)
Keywords
Where 杭州胡庆余堂药业有限公司 is headquartered
LocationHeadquarters
- HQ city
- 杭州市, 浙江省
- HQ country
- China
- HQ region
- Asia
Offices1 record
Markets served
杭州胡庆余堂药业有限公司 business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Prescription Pharmaceuticals (处方药): Prescription TCM products sold through hospitals and medical institutions, including products like 胃复春片, 安宫牛黄丸, and others covered under national and provincial medical insurance schemes.
- OTC Products (非处方药): Over-the-counter TCM products sold through retail pharmacies and drug stores, including health products like 铁皮枫斗晶, 参参胶囊, and various patent medicines.
- Health Supplements (保健品): Health food products including 铁皮枫斗晶, 蜂胶胶囊, 参参胶囊, 强力片, marketed for immune enhancement, fatigue relief, and general wellness.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
杭州胡庆余堂药业有限公司 product offering
Product offeringCore offering
Hangzhou Huqingyutang Pharmaceutical Co., Ltd. is a traditional Chinese medicine (TCM) manufacturer producing prescription drugs, OTC drugs, and health supplements across 12 dosage forms (丸、散、膏、丹、曲、露、油、酒、片剂、胶囊、颗粒剂) at a 107-acre GMP-certified facility in Hangzhou. The company's 182 nationally approved pharmaceutical products serve both hospital/medical-institution channels (e.g., Weifuchun for gastric precancerous lesions, Angong Niuhuang Wan for emergency care) and retail pharmacy/consumer channels (e.g., Ejiao, Tiepi Fengdou Jing, Shen Shen Capsules).
Product overview
杭州胡庆余堂药业有限公司是一家具有150年历史的传统中药企业,享有"江南药王"美誉。公司生产丸、散、膏、丹、曲、露、油、酒、片剂、胶囊、颗粒剂等多种剂型产品,涵盖182只国家批准生产的药品和9只保健食品。核心产品包括安宫牛黄丸(国家基本药物、急抢救药)、胃复春片/胶囊(国内唯一CFDA审批主治胃癌癌前期病变的中成药)、阿胶、强力枇杷露等。产品分为处方药系列、非处方药系列、保健品系列三大类别,形成了从补益类、呼吸系统、消化系统到妇科、眼科等多科室的完整产品线。
Differentiator
Problem solved
Functional benefit
Products and services
- Angong Niuhuang Wan (安宫牛黄丸) Classical TCM formulation for clearing heat and detoxification, restoring consciousness. Used for high fever, coma, stroke, encephalitis, meningitis, toxic encephalopathy, cerebral hemorrhage, and sepsis. Classified as a national essential drug, emergency-rescue medication, and Category A medical insurance drug.
- Weifuchun Tablets (胃复春片) TCM formulation for strengthening spleen and replenishing qi, activating blood and detoxifying. Used for gastric precancerous lesions, adjuvant post-gastric cancer surgery treatment, and chronic superficial gastritis with spleen-stomach deficiency. The only CFDA-approved TCM for treating gastric precancerous lesions in China; National Class 2 Protected TCM Variety.
- Weifuchun Capsules (胃复春胶囊) Capsule form of the Weifuchun formulation for strengthening spleen and replenishing qi, activating blood and detoxifying. Used for gastric precancerous lesions, adjuvant post-gastric cancer surgery treatment, and chronic superficial gastritis with spleen-stomach deficiency.
- Huqingyutang Brand Ejiao (胡庆余堂阿胶) Traditional donkey-hide gelatin (Ejiao) product for blood enrichment, nourishment, moistening dryness, and hemostasis. Used for blood-deficiency symptoms including sallow complexion, dizziness, palpitations, irritability, insomnia, and lung-dryness cough. Made through over 50 traditional processes with approximately 150 years of brand heritage.
- Qiangli Pipa Lu (强力枇杷露) TCM oral solution for nourishing yin, moistening lungs, relieving cough and resolving phlegm. Used for bronchitis-related cough. National essential drug, low-price drug, and Category B medical insurance drug.
- Wubi Shanyao Wan (无比山药丸) TCM pill formulation for strengthening spleen and tonifying kidney. Used for spleen-kidney deficiency, poor appetite, emaciation, soreness in the lower back and knees, dizziness and tinnitus. National exclusive product and Zhejiang Province medical insurance product.
- Zengru Koufuye (增乳口服液) TCM oral solution for replenishing qi, nourishing blood, and promoting lactation. Used for postpartum insufficient milk production. National exclusive product.
- Tiepi Fengdou Jing (铁皮枫斗晶) Health supplement made from Tiepi Shijian (Dendrobium), American ginseng, and glucose. Animal-tested for immune regulation and anti-fatigue health functions.
- Shen Shen Capsules (参参胶囊) Health supplement made from sun-dried ginseng and American ginseng. Animal-tested for immune regulation and anti-fatigue health functions.
- Fengjiao Capsules (蜂胶胶囊) Health supplement made from propolis, American ginseng, and starch. Animal-tested for enhancing immunity and relieving physical fatigue.
- Qiangli Tablets (强力片) Health supplement with animal-tested anti-fatigue and immune-regulating health functions.
- Chenxiang Qu (沉香曲) TCM Qu (fermented) preparation for relieving exterior symptoms and resolving stagnation, soothing liver and harmonizing stomach. Used for residual exterior pathogens, liver-stomach qi stagnation, chest and hypochondriac distension, and acid reflux. Drinking-tablet dosage form.
- Dabuyin Wan (大补阴丸) TCM pill formulation for nourishing yin and reducing fire. Used for yin-deficiency fire effulgence, tidal fever with night sweats, cough, tinnitus, and seminal emission.
- Tiaojing Yangxue Wan (调经养血丸) TCM pill formulation for tonifying blood, regulating qi, and regulating menstruation. Used for blood deficiency with qi stagnation, irregular menstruation, and lower back and abdominal distension.
- Shenlu Qiangshen Wan (参鹿强身丸) TCM pill formulation for nourishing and strengthening the body, benefiting the kidney. Used for physical weakness, lack of spirit, and lower back and leg soreness.
- Shengui Yangrong Wan (参桂养荣丸) TCM pill formulation for replenishing qi and tonifying blood, nourishing the heart and calming the spirit. Used for qi and blood deficiency, palpitations and forgetfulness, and physical fatigue.
- Qingyu Biwen Dan (庆余辟瘟丹) TCM Dan preparation for dispelling pestilential qi and preventing vomiting and diarrhea. Used for exposure to summer-heat evil, time-of-travel miasma, dizziness, chest tightness, and abdominal pain with vomiting and diarrhea. Prescription drug.
- Chenxiang Huaqi Capsules (沉香化气胶囊) TCM capsule formulation for regulating qi and soothing liver, dissolving accumulation and harmonizing stomach. Used for liver-stomach qi stagnation, chest and abdominal distension, belching and acid reflux.
- Wuji Baifeng Wan (乌鸡白凤丸) TCM pill formulation for tonifying qi and nourishing blood, regulating menstruation and stopping leukorrhea. Used for qi and blood deficiency, weakness, soreness in lower back and knees, irregular menstruation, and leukorrhea.
- Tongbian Ling Capsules (通便灵胶囊) TCM capsule formulation for clearing heat, draining stagnation, and moistening intestines to relieve constipation. Used for heat-constipation, long-term bed-rest constipation, acute abdominal distension with constipation, and habitual constipation in the elderly.
- Xiaoyao Wan (逍遥丸, Water Pill) TCM water pill formulation for soothing liver and strengthening spleen, nourishing blood and regulating menstruation. Used for liver-depression and spleen-deficiency causing chest distress, hypochondriac pain, dizziness, poor appetite, and irregular menstruation.
- Erlong Zuoci Wan (耳聋左慈丸) TCM pill formulation for nourishing kidney and calming liver. Used for liver-kidney yin deficiency, tinnitus, deafness, dizziness, and blurred vision.
- Xiangsha Liujun Wan (香砂六君丸) TCM pill formulation for replenishing qi and strengthening spleen, harmonizing stomach. Used for spleen-deficiency qi stagnation, indigestion, belching and poor appetite, chest and abdominal distension, and loose stools.
- Huqingyutang Brand Pharmaceutical Manufacturing (丸、散、膏、丹、曲、露、油、酒、片剂、胶囊、颗粒剂) Multi-dosage-form contract manufacturing offering covering pills (丸), powders (散), ointments (膏), Dan preparations (丹), Qu fermented preparations (曲), distillates (露), oils (油), medicinal wines (酒), tablets (片剂), capsules (胶囊), and granules (颗粒剂) for traditional Chinese medicine products.
Quantifiable outcome
- 胃复春 clinical study showed 88.1% symptom improvement rate and 63.3% pathological regression rate for gastric low-grade intraepithelial neoplasia
- +3 more outcomes
Companies that use 杭州胡庆余堂药业有限公司
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles3 records
杭州胡庆余堂药业有限公司 technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
杭州胡庆余堂药业有限公司 partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and minor.
- 浙江中医药大学 (Zhejiang University of Traditional Chinese Medicine)coreEstablished the '胡庆余堂·冯根生奖学金' (Hu Qingyu Tang · Feng Gensheng Scholarship) with an investment of 4 million RMB to support outstanding students in Traditional Chinese Medicine and Pharmacy disciplines, promoting TCM talent development and cultural heritage.
- 浙江省血液中心 (Zhejiang Blood Center)minorLaunched the '胡庆余堂爱心献血周' (Hu Qingyu Tang Love Blood Donation Week) charity initiative. The company collaborates with Zhejiang Blood Center to organize blood donation drives and promote public health responsibility, distributing 3,500 gift packages to blood donors.
- 天津中医药大学 (Tianjin University of TCM)coreAcademic research collaboration partner for traditional Chinese medicine product development, representing one of several top TCM research institutions Hu Qingyu Tang cooperates with for new drug research and product optimization.
- 南京中医药大学 (Nanjing University of TCM)coreAcademic research collaboration partner for traditional Chinese medicine product development and clinical research.
- 浙江大学 (Zhejiang University)coreIndustry-academia-research collaboration partner. In 2026, the company partnered with Zhejiang University for '营销管理与创新实战' (Marketing Management and Innovation Practice) training programs to enhance employee capabilities.
- 浙江省食品药品检验研究院 (Zhejiang Institute for Food and Drug Control)minorQuality testing and inspection cooperation partner. In 2019, the company signed strategic cooperation agreement to enhance TCM industry chain quality inspection capabilities.
- 农业农村部茶叶质量监督检验测试中心 (MOA Tea Quality Supervision and Testing Center)minorQuality testing and inspection cooperation partner for improving quality assurance system.
- 安徽省金寨县 (Jinzhai County, Anhui Province)minorEstablished traditional Chinese medicine planting base in Anhui Province's Jinzhai County to support poverty alleviation through TCM agriculture. The company provides seedlings to local farmers and purchases medicinal materials, contributing to rural economic development.
Scale indicators7 records
Recent moves8 records
Expansion highlights6 records
杭州胡庆余堂药业有限公司 competitors and assessment
Company assessmentDirect peers
- Taiji Group (太极集团): Taiji Group is a major Chinese TCM manufacturer with a broad product portfolio across multiple therapeutic categories and dosage forms. Both companies operate similar manufacturing models with hospital and retail distribution channels, competing in TCM specialty categories including digestive health, tonics, and emergency medicine formulations.
- Buchang Pharma (步长制药): Buchang Pharma is a major Chinese TCM pharmaceutical company with strong hospital-channel presence and broad prescription TCM portfolio. Both companies compete in the prescription TCM category with similar channel strategies, product positioning, and focus on classical formulas distributed through hospital procurement.
- Yunnan Baiyao (云南白药): Yunnan Baiyao is a major branded TCM manufacturer with similar scale, broad product portfolio, and inclusion in hospital and retail channels. Both companies compete in the specialty TCM segment with strong consumer brand recognition, multiple dosage form manufacturing, and similar channel strategies across prescription and OTC categories.
- Guilin Sanjin (桂林三金): Guilin Sanjin is a branded TCM manufacturer focused on specialty products including oral care and herbal formulas. Both companies operate in specialty TCM segments with branded product strategies, hospital channel access, and similar positioning around traditional Chinese medicine formulations across multiple dosage forms.
- Jiuzhitang (九芝堂): Jiuzhitang is another heritage Chinese TCM brand (300+ years old) with a similar product portfolio of classical formulas and tonics. Both companies share heritage positioning, broad dosage form manufacturing, similar distribution through hospital and retail channels, and similar focus on traditional Chinese medicine preparations.
- Beijing Tongrentang (同仁堂): Tongrentang is China's most iconic TCM heritage brand (founded 1669, 350+ years), operating as a state-owned enterprise with a similar product portfolio of classical TCM formulas, tonics, and prescription medicines. Both companies share premium heritage positioning, multiple insurance listings, broad dosage form manufacturing, and the '北同仁堂,南庆余堂' market pairing that makes them the most direct comparison in China's TCM industry.
- Pien Tze Huang (片仔癀): Pien Tze Huang is a 500+ year heritage TCM brand with similar regulatory exclusivity patterns (state-protected formula) and premium pricing strategy. Both companies occupy the heritage/premium tier of the Chinese TCM market with strong consumer brand loyalty, state-level protection, and similar positioning as cultural heritage brands.
- Dong-E E-Jiao (东阿阿胶): Dong-E E-Jiao is the leading Ejiao manufacturer in China and was ranked alongside Hu Qingyu Tang in the 2018 Top 10 Ejiao Industry Brands (Hu Qingyu Tang ranked 3rd). Both companies compete directly in the Ejiao/TCM tonic category, making this the most direct competitor for one of Hu Qingyu Tang's flagship product lines with similar premium positioning.
Broad incumbents
- China Resources Sanjiu (华润三九): China Resources Sanjiu is a larger state-owned TCM player with a broader portfolio including OTC, prescription, and consumer health products. The company operates at significantly larger scale than Hu Qingyu Tang, serving as a broad incumbent in the TCM space with similar channel strategies and state-owned corporate backing.
- Baiyunshan (白云山): Baiyunshan, part of the larger Guangzhou Pharmaceutical (GPC) state-owned group, is a major incumbent in TCM and Western medicine. Both companies operate as TCM manufacturers under state-owned umbrellas with hospital and retail channel strategies, though Baiyunshan has significantly broader product portfolio and geographic reach.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
杭州胡庆余堂药业有限公司 social profiles
Digital presence杭州胡庆余堂药业有限公司 compliance and trust
Trust signalCompliance5 records
杭州胡庆余堂药业有限公司 financial estimates
Financial estimateRevenue estimate
Valuation estimate
杭州胡庆余堂药业有限公司 leadership team
Management profileNumber of profiles
Profiles7 records
杭州胡庆余堂药业有限公司 funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
杭州胡庆余堂药业有限公司 M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about 杭州胡庆余堂药业有限公司
What does 杭州胡庆余堂药业有限公司 do?
Hangzhou Huqingyutang Pharmaceutical Co., Ltd. is a traditional Chinese medicine (TCM) manufacturer producing prescription drugs, OTC drugs, and health supplements across 12 dosage forms (丸、散、膏、丹、曲、露、油、酒、片剂、胶囊、颗粒剂) at a 107-acre GMP-certified facility in Hangzhou. The company's 182 nationally approved pharmaceutical products serve both hospital/medical-institution channels (e.g., Weifuchun for gastric precancerous lesions, Angong Niuhuang Wan for emergency care) and retail pharmacy/consumer channels (e.g., Ejiao, Tiepi Fengdou Jing, Shen Shen Capsules).
Is 杭州胡庆余堂药业有限公司 a public or private company?
杭州胡庆余堂药业有限公司 is a private company. It is classified as corporate owned and is currently operating.
When was 杭州胡庆余堂药业有限公司 founded?
杭州胡庆余堂药业有限公司 was founded in 1874. It employs 11 to 50 people.
Where is 杭州胡庆余堂药业有限公司 based?
杭州胡庆余堂药业有限公司 is headquartered in 杭州市, 浙江省, China, in the Asia region.
How does 杭州胡庆余堂药业有限公司 make money?
Three revenue lines are on record. Prescription Pharmaceuticals (处方药) is the primary driver. The others are OTC Products (非处方药) and health Supplements (保健品).
Who are 杭州胡庆余堂药业有限公司's main competitors?
Direct peers on record are Taiji Group (太极集团), Buchang Pharma (步长制药), Yunnan Baiyao (云南白药), Guilin Sanjin (桂林三金), Jiuzhitang (九芝堂), Beijing Tongrentang (同仁堂), Pien Tze Huang (片仔癀) and Dong-E E-Jiao (东阿阿胶). Broad incumbents are China Resources Sanjiu (华润三九) and Baiyunshan (白云山).
Does 杭州胡庆余堂药业有限公司 have an API?
No public API is recorded for 杭州胡庆余堂药业有限公司.
What industry is 杭州胡庆余堂药业有限公司 in?
杭州胡庆余堂药业有限公司's product category is Traditional Chinese Medicine (TCM) Pharmaceuticals. Its primary akta.pro industry code is HLAIAAAB, Specialty Care Pharmaceuticals, with a secondary code of CRADAMAD, Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges). Its NAICS code is 3254 and its SIC code is 2834.